RESUMO
A multidisciplinary Adverse Drug Reaction (ADR) committee consisting of pharmacists, nurses, and physician was formed. The committee developed an ADR Reporting Form and a 24-hour ADR Reporting Hotline to simplify ADR Reporting throughout the hospital. An ADR Newsletter and an extensive inservice education program was also implemented. Suspected ADRs are investigated by a pharmacist and presented to committee. A formal report is then forwarded to the Pharmacy and Therapeutics Committee, as well as the clinical departments within the hospital. The establishment of a formalized multidisciplinary ADR committee was successful in generating 2.1 ADR reports per 100 hospital admissions. These ADRs were reported from a variety of healthcare professionals.
Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos/organização & administração , Comitê de Profissionais/organização & administração , Controle de Formulários e Registros , Humanos , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Estados UnidosRESUMO
A prospective, randomized, crossover study was performed with seven healthy volunteers to address the effect of increased gastric pH on dapsone absorption. Subjects were randomized to receive a single 100-mg dose of dapsone or a single 100-mg dose of dapsone in addition to 30 ml of a high potency antacid 1 h before dapsone administration and hourly thereafter for a total of 10 doses. Dapsone concentrations in serum were measured periodically for 48 h. No statistical differences between the two regimens were noted when mean dapsone maximal initial concentrations, times to peak, and areas under the curve were compared. These data suggest that an increase in gastric pH has little or no effect on the absorption of dapsone in healthy subjects.
Assuntos
Antiácidos/farmacologia , Dapsona/farmacocinética , Ácido Gástrico/metabolismo , Absorção Intestinal , Adulto , Estudos Cross-Over , Dapsona/sangue , Dapsona/metabolismo , Relação Dose-Resposta a Droga , Interações Medicamentosas , Feminino , Mucosa Gástrica/efeitos dos fármacos , Humanos , Concentração de Íons de Hidrogênio , Masculino , Estudos ProspectivosRESUMO
The causes and management of endocrine disorders associated with human immunodeficiency virus (HIV) infection are reviewed. Endocrine disorders observed in HIV-positive patients include adrenal abnormalities, hyporeninemic hypoaldosteronism, pituitary insufficiency, pancreatic abnormalities, thyroid and parathyroid disorders, and testicular abnormalities. Opportunistic pathogens implicated in these disorders include cytomegalovirus, Cryptococcus, Toxoplasma, mycobacteria, Candida, and Aspergillus. Neoplasma such as Kaposi's sarcoma and lymphoma can also cause endocrine abnormalities. Several drugs used in patients with the acquired immunodeficiency syndrome (AIDS) are associated with the development of endocrine disorders. These drugs include ketoconazole, itraconazole, rifampin, vidarabine, pentamidine, trimethoprim-sulfamethoxazole, didanosine, and ganciclovir. Severe patient debilitation can contribute to the development of endocrine abnormalities. Monitoring of adrenal gland function may be prudent in HIV-infected patients who have nonspecific symptoms of adrenal insufficiency. If adrenal insufficiency is diagnosed, replacement therapy with oral hydrocortisone is required. Administration of fludrocortisone can rapidly alleviate the signs and symptoms of hyporeninemic hypoaldosteronism. Fluid restriction is the first step in managing the pituitary abnormality known as the syndrome of inappropriate secretion of antidiuretic hormone. Drug-induced endocrine abnormalities often resolve after withdrawal of the offending agent. Endocrine complications in HIV-infected patients may be caused by infection, malignancy, or drugs. Adjusting or instituting drug therapy may be necessary to control symptomatic endocrine abnormalities.
Assuntos
Doenças do Sistema Endócrino/etiologia , Infecções por HIV/complicações , Doenças das Glândulas Suprarrenais/etiologia , Anti-Infecciosos/efeitos adversos , Infecções por HIV/tratamento farmacológico , Humanos , Hipoaldosteronismo/etiologia , Masculino , Pancreatopatias/etiologia , Doenças das Paratireoides/etiologia , Doenças Testiculares/etiologia , Doenças da Glândula Tireoide/etiologiaRESUMO
OBJECTIVE: To report a case of possible ganciclovir-induced psychiatric disturbances. CASE SUMMARY: A patient with AIDS who had no known psychiatric history and mild renal dysfunction experienced exacerbation of cytomegalovirus retinitis and was treated with ganciclovir 5 mg/kg iv q12h. The patient complained of nightmares and developed visual hallucinations and severe agitation on day 15 of ganciclovir therapy. The problems resolved after haloperidol administration and ganciclovir withdrawal and reappeared when the same regimen was reinstituted. However, the patient was able to tolerate the maintenance dose of ganciclovir at 5 mg/kg/d along with haloperidol later without further episodes of visual hallucinations. DISCUSSION: Case reports in the literature on ganciclovir-or its analog, acyclovir-, induced psychiatric disturbances were reviewed and compared. The potential relationship between ganciclovir accumulation in patients with renal insufficiency and the observed central nervous system problems in our patient was postulated. CONCLUSIONS: It is likely that ganciclovir accumulation contributed to the acute psychotic episodes observed in our patient. Adjusting ganciclovir dosage based on the patient's renal function is probably the only approach required to prevent or reduce the incidence of these episodes.
Assuntos
Ganciclovir/efeitos adversos , Transtornos Neurocognitivos/induzido quimicamente , Síndrome da Imunodeficiência Adquirida/complicações , Infecções por Citomegalovirus/tratamento farmacológico , Infecções por Citomegalovirus/microbiologia , Sonhos/efeitos dos fármacos , Feminino , Ganciclovir/administração & dosagem , Ganciclovir/uso terapêutico , Alucinações/induzido quimicamente , Humanos , Injeções Intravenosas , Nefropatias/complicações , Masculino , Pessoa de Meia-Idade , Retinite/tratamento farmacológico , Retinite/microbiologiaAssuntos
Síndrome da Imunodeficiência Adquirida/complicações , Infecções Oportunistas/tratamento farmacológico , Infecções Bacterianas/tratamento farmacológico , Educação Continuada em Enfermagem , Humanos , Micoses/tratamento farmacológico , Enfermagem Prática/educação , Pneumonia por Pneumocystis/tratamento farmacológico , Infecções por Protozoários/tratamento farmacológico , Viroses/tratamento farmacológicoAssuntos
Síndrome da Imunodeficiência Adquirida/enfermagem , Síndrome da Imunodeficiência Adquirida/classificação , Síndrome da Imunodeficiência Adquirida/microbiologia , Síndrome da Imunodeficiência Adquirida/terapia , Educação Continuada em Enfermagem , Feminino , Humanos , Masculino , Enfermagem Prática/educação , Fatores de RiscoRESUMO
A rare complication of nonsteroidal antiinflammatory drug (NSAID) use, particularly in patients with collagen vascular or autoimmune diseases, is aseptic meningitis. A healthy 21-year-old man receiving naproxen for muscle spasm was admitted with a chief complaint of severe headache. Approximately one week after beginning naproxen, the patient developed headache, fever (T 38.8 degrees C), shaking chills, and nuchal rigidity with occasional nausea and vomiting resulting in a 15-lb weight loss. Findings from a cerebrospinal fluid examination revealed polymorphonuclear pleocytosis and elevated protein, but no evidence of infection with bacteria, fungi, mycobacteria, or viral agents was noted. Within 36 hours of discontinuing naproxen, the meningitis-like symptoms markedly improved. Rechallenge with naproxen was not performed. In patients exhibiting meningitis-like symptoms, a thorough drug history, including that of recent or intermittent NSAID use, should be obtained.